Contact us for all you need to know on the NIH Final Rule and its impact on registration and results disclosures.
MMS combines over a decade of staff expertise, proven processes, and exclusive technology to achieve comprehensive disclosure reporting for US and International Registries. Our integrated disclosure solution allows MMS to be your centralized disclosure department and manage all workflow and data summarization obligations for an entire drug development pipeline. Let MMS seamlessly integrate into your organization with the following service offerings:
- Protocol and results registration on CT.gov, EudraCT and other global registries
- Full workflow management
- Provision of summary writers and QC analysts for overall workflow management
- Ability to integrate with your systems to help leverage existing data, gain efficiencies, and improve reporting accuracy
State of the Art Technology
Through our partnership with TrialAssure® we offer disclosure and transparency reporting software that summarizes your data and facilitates workflows in a comprehensive, cost-effective manner. To learn more about the TrialAssure® system, visit their website.